Is CAS ruling on UV light blood treatments consistent?
By Dr Ben Koh published on 20 August 2013
It was previously reported in 2012 that Germany’s National Anti-doping agency (NADA) had investigated the use of UV light blood treatment by athletes as potentially a violation of national anti-doping rules1. While the World Anti-Doping Agency (WADA) on 30 January 20122 and the German Sports Arbitration court on 2 Nov 20123 had both deemed that such UV treatments prior to 2011 were not in violation of the anti-doping code, the German NADA disagreed with that position and raised the case to the Court of Arbitration for Sport (CAS) for clarification.
To continue reading this article, and thousand like it, sign-up here for free.
If you are a regular reader and/or you are using LawInSport for professional purposes you may wish to upgrade your account to Plus Membership for under £4 per week. You can view all our membership plans here.
For corporate and academic institutional membership email firstname.lastname@example.org.
This work was written for and first published on LawInSport.com (unless otherwise stated) and the copyright is owned by LawInSport Ltd. Permission to make digital or hard copies of this work (or part, or abstracts, of it) for personal use, professional training and/orclassroom uses is granted free of charge provided that such copies are not made or distributed for profit or commercial advantage, and provided that all copies bear this notice and full citation on the first page (which should include the URL, company name (LawInSport), article title, author name, date of the publication and date of use) of any copies made. Copyright for components of this work owned by parties other than LawInSport must be honoured.
- Anti-Doping | ASADA | Australia | Court of Arbitration for Sport (CAS) | Erythropoietin (EPO) | Germany | National Anti-Doping Agency Germany | World Anti-Doping Agency (WADA)
- What can be done to revive the fight against doping and dopers in sport?
- A tarnished Silver Jubilee: doping in sport 25 years after Johnson and Delgado
- Unheard voices of racism and sexism in sport: Is anti-doping but another “ism” in fairer clothes?
- Anti-doping update from Australia with Paul Horvath
- Anti-doping and medical privacy
About the Author
Dr Ben Koh is the bancassurance Chief Medical Officer leading the medical risk team at one of the world’s largest bank, the Commonwealth Bank of Australia. He has clinical and educational training in surgery, sports medicine, emergency medicine and critical care. He was previously an elite swimmer and completed his PhD at the faculty of business, University of Technology Sydney.